DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/t4nhcg/colpotrophine) has announced the addition of the "Colpotrophine (Postmenopausal Vaginal Atrophy) - Forecast and Market Analysis to 2022" report to their offering.
Although the postmenopausal vaginal atrophy (PVA) market has experienced anemic growth over the past decade, it is expected to undergo a considerable change between 2012 and 2022. This market has historically had a large untreated population due to: low diagnosis rates, safety issues with the existing therapies, and poor patient compliance. Since the mainstay estrogen-based therapies are associated with causing elevated risk for breast cancer, endometrial cancer, and stroke, many women go untreated.
Theramex's Colpotrophine (promestriene) consists of a synthetic estrogen that is used exclusively for local application and acts on the lining of the vagina and vulva. This product is indicated for the treatment of VVA, vulvar itching, vulvar dryness, and vulvar kraurosis. It is also used for treating delayed vaginal healing postpartum. Colpotrophine is available in two dosage forms: as a cream and a capsule.
- Overview of PVA, including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines as well as an overview on the competitive landscape.
- Detailed information on Colpotrophine including product description, safety and efficacy profiles as well as a SWOT analysis.
- Sales forecast for Colpotrophine for the top seven countries from 2012 to 2022.
- Sales information covered for the US, France, Germany, Italy, Spain, the UK and Japan.
Key Topics Covered:
1.1 List of Tables
3 Disease Overview
4 Disease Management
5 Competitive Assessment
6 Colpotrophine (promestriene vaginal cream/ovule)
For more information visit http://www.researchandmarkets.com/research/t4nhcg/colpotrophine
About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.